APRE vs VRTX: Which Stock is Better?
Side-by-side comparison of Aprea Therapeutics Inc and Vertex Pharmaceuticals Inc in 2026
APRE
Aprea Therapeutics Inc
$0.88
VRTX
Vertex Pharmaceuticals Inc
$442.08
Key Metrics Comparison
| Metric | APRE | VRTX | Winner |
|---|---|---|---|
| Market Cap | $6.22M | $113.35B | VRTX |
| P/E Ratio | N/A | 31.15 | VRTX |
| EPS (TTM) | $N/A | $14.19 | VRTX |
| Revenue Growth | -1.0% | 0.1% | VRTX |
| Gross Margin | -1619.1% | 52.7% | VRTX |
Analyze APRE
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APRE or VRTX a better investment?
Comparing APRE and VRTX: Aprea Therapeutics Inc has a market cap of $6.22M while Vertex Pharmaceuticals Inc has $113.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APRE and VRTX?
APRE (Aprea Therapeutics Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APRE or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: APRE or VRTX?
VRTX has higher revenue growth at 0.1% vs -1.0% for APRE.
Which company is more profitable: APRE or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 52.7% compared to -1619.1% for APRE.
Which is the larger company: APRE or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.35B compared to $6.22M for APRE.
Should I buy APRE or VRTX in 2026?
Both APRE and VRTX have investment merit. APRE trades at $0.88 while VRTX trades at $442.08. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APRE and VRTX stock?
Key differences: Market Cap ($6.22M vs $113.35B), P/E Ratio (N/A vs 31.2x), Revenue Growth (-1.0% vs 0.1%), Gross Margin (-1619.1% vs 52.7%).